NG101m Adjuvant Therapy in Glioblastoma Patients

NCT04373785 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

RADIATION: Intensity-modulated radiation therapy
DRUG: Temozolomide
DRUG: NG101m

Sponsor

NeuGATE Theranostics